Updated: October 14, 2026
The U.S. Food and Drug Administration (FDA) has withdrawn its proposed rule requiring standardized asbestos testing for talc-containing cosmetic products.
Originally announced in December 2024, the proposal aimed to strengthen consumer protection by establishing consistent methods for detecting asbestos contamination.
However, on November 28, 2025, the FDA officially withdrew the proposed requirements following a review of public comments.
This development changes the regulatory outlook for cosmetic manufacturers, testing laboratories, and businesses using talc in their products.
What Was the FDA’s Proposed Asbestos Testing Rule?
In December 2024, the FDA proposed regulations establishing standardized methods for detecting and identifying asbestos in talc-containing cosmetics.
The proposal was developed under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
It focused on improving consistency in laboratory testing and reducing the risk of asbestos contamination in cosmetic products.
The proposed requirements included specific analytical testing methods and related obligations for affected manufacturers.
However, these requirements were never finalized under the 2024 proposal.
Why Did the FDA Withdraw the Talc Testing Proposal?
On November 28, 2025, the FDA announced the withdrawal of its proposed asbestos-testing regulation.
The agency explained that public comments raised scientific, technical, and legal questions requiring additional consideration.
These concerns included the reliability of testing methods and questions about the FDA’s regulatory authority.
The withdrawal allows the agency to reconsider its approach before developing revised requirements.
Importantly, the decision does not mean asbestos contamination is no longer a safety concern.
FDA Asbestos Testing Rule: Current Status in 2026
As of October 2026, the December 2024 proposed rule has been withdrawn.
Therefore, its proposed standardized testing requirements are not enforceable as a final FDA regulation.
The regulatory timeline includes:
- December 26, 2024: FDA announced the proposed asbestos-testing rule.
- December 27, 2024: Proposal published in the Federal Register.
- March 27, 2025: Public comment period ended.
- November 28, 2025: FDA officially withdrew the proposal.
The withdrawn proposal has no effective date or compliance deadline.
However, the FDA has indicated that it intends to develop another proposal addressing standardized testing under MoCRA.
Businesses should distinguish between existing cosmetic safety obligations and testing requirements that have not been finalized.
Why Is Asbestos in Talc a Safety Concern?
Talc is a naturally occurring mineral used in several cosmetic products, including powders, blushes, and other personal care formulations.
Asbestos is also a naturally occurring mineral. Because talc and asbestos deposits can occur near each other, contamination is possible.
Asbestos is a known human carcinogen, making contamination an important consumer safety concern.
Testing and appropriate supplier controls can help manufacturers identify potential risks before products reach consumers.
What Does the Withdrawal Mean for Cosmetic Manufacturers?
The FDA’s withdrawal changes the status of the proposed testing requirements, but it does not eliminate existing product safety responsibilities.
Cosmetic manufacturers remain subject to applicable provisions of the Federal Food, Drug, and Cosmetic Act and MoCRA.
Businesses should continue assessing ingredient quality, potential contamination, and product safety.
Important considerations include:
- Supplier verification: Review the quality and sourcing of talc ingredients.
- Risk assessment: Evaluate potential asbestos contamination risks.
- Testing practices: Consider scientifically appropriate methods for evaluating product safety.
- Documentation: Maintain relevant supplier, testing, and quality records.
- Regulatory monitoring: Follow future FDA proposals and official requirements.
These measures can support responsible product development while regulatory requirements continue to develop.
How MoCRA Affects Talc-Containing Cosmetics
The Modernization of Cosmetics Regulation Act of 2022 introduced significant changes to federal cosmetics regulation.
Among its provisions, Section 3505 directs the FDA to establish standardized methods for detecting and identifying asbestos in talc-containing cosmetic products.
The December 2024 proposal was intended to help fulfill this requirement.
Although the FDA withdrew that proposal, the underlying statutory obligation remains.
Future regulatory action may establish revised testing requirements after further scientific and legal review.
What Happens Next for FDA Talc Regulations?
The FDA has stated that it plans to issue another proposed rule addressing asbestos testing in talc-containing cosmetics.
However, manufacturers should not treat an anticipated proposal as a finalized requirement.
Any future regulation will need to be assessed according to its published provisions, regulatory status, and applicable dates.
Until then, businesses should monitor official FDA announcements and continue meeting existing cosmetic safety requirements.
Final Thoughts
The FDA’s withdrawal of the proposed asbestos-testing rule marks an important change from the regulatory position announced in December 2024.
Although the proposal was intended to improve testing consistency, it did not become a final regulation.
As of October 2026, the withdrawn proposal has no compliance deadline.
For cosmetic manufacturers, the priority remains maintaining product safety, following applicable requirements, and preparing for potential future regulatory changes.
Sources: FDA Talc Regulatory Updates | Federal Register Withdrawal Notice
